Prometheusbiosciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for inflammatory skin conditions.

Moonlake immunotherapeuticsAbbvie incMerck kgaaMerck co incPrometheusbiosciences incEli lilly and co llyacquisitionMerck kgaDice therapeuticsInexpensive valuationStrong catalyst